Log In
Print
BCIQ
Print
Print this Print this
 

Verigene Clopidogrel Metabolism Nucleic Acid Test, Verigene CYP2C19 Nucleic Acid Test

  Manage Alerts
Collapse Summary General Information
Company Nanosphere Inc.
DescriptionGenetic lab test that detects variants of the CYP2C19 gene
Molecular Target Cytochrome P450 2C19 (CYP2C19)
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationGenetic disorders, Diagnostic
Indication DetailsDetect variants to the CYP2C19 gene to guide proper Clopidogrel therapy for patients undergoing percutaneous coronary intervention
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today